| Literature DB >> 25436515 |
Mohammadreza Amiri, Hazreen Abdul Majid, FarizahMohd Hairi, Nithiah Thangiah, Awang Bulgiba, Tin Tin Su.
Abstract
OBJECTIVES: The objectives are to assess the prevalence and determinants of cardiovascular disease (CVD) risk factors among the residents of Community Housing Projects in metropolitan Kuala Lumpur, Malaysia.Entities:
Mesh:
Year: 2014 PMID: 25436515 PMCID: PMC4251129 DOI: 10.1186/1471-2458-14-S3-S3
Source DB: PubMed Journal: BMC Public Health ISSN: 1471-2458 Impact factor: 3.295
Socio-demographic characteristics of the study (n = 1,096).
| Variables | Sub-categories | N (%) |
|---|---|---|
| 288 (26.3) | ||
| 213 (19.4) | ||
| 255 (23.3) | ||
| 201 (18.4) | ||
| 139 (12.7) | ||
| 479 (43.7) | ||
| 517 (56.3) | ||
| 899 (82.1) | ||
| 181 (16.5) | ||
| 16 (1.4) | ||
| 78 (7.1) | ||
| 186 (17.0) | ||
| 718 (65.5) | ||
| 114 (10.4) | ||
| 192 (17.5) | ||
| 904 (82.5) | ||
| 463 (42.2) | ||
| 138 (12.6) | ||
| 42 (3.8) | ||
| 237 (21.6) | ||
| 216 (19.7) | ||
| 277 (25.3) | ||
| 701 (64.0) | ||
| 67 (6.1) | ||
| 51 (4.6) |
Prevalence of individual CVD risk factors (n = 1,096).
| Hypertension | Hypercholesterolemia | Smoking | Diabetes | Obesity | At least one | |||
|---|---|---|---|---|---|---|---|---|
| | 45 (15.6) | 110 (38.2) | 35 (12.2) | 59 (20.5) | 6 (2.1) | 28 (9.7) | 113 (39.2) | 185 (64.2) |
| | 47 (22.1) | 100 (46.9) | 45 (21.1) | 79 (37.1) | 11 (5.2) | 39 (18.3) | 111 (52.1) | 181 (85.0) |
| | 109 (42.8) | 159 (62.4) | 49 (19.2) | 109 (42.8) | 17 (6.7) | 38 (14.9) | 164 (64.3) | 232 (91.0) |
| | 128 (63.7) | 124 (61.7) | 28 (13.9) | 93 (46.3) | 36 (17.9) | 31 (15.4) | 128 (63.7) | 195 (97.0) |
| | 102 (73.4) | 71 (51.1) | 22 (15.8) | 76 (54.7) | 16 (11.5) | 22 (15.8) | 84 (60.4) | 133 (95.7) |
| | ||||||||
| | 42 (53.9) | 39 (50.0) | 11 (14.1) | 33 (42.3) | 6 (7.7) | 6 (7.7) | 43 (55.1) | 67 (85.9) |
| | 109 (58.6) | 92 (49.5) | 28 (15.1) | 80 (43.0) | 22 (11.8) | 33 (17.7) | 112 (60.2) | 168 (90.3) |
| | 261 (36.4) | 386 (53.8) | 126 (17.6) | 267 (37.2) | 53 (7.4) | 105 (14.6) | 389 (54.2) | 610 (85.0) |
| | 19 (16.7) | 47 (41.2) | 14 (12.3) | 36 (31.6) | 5 (4.4) | 14 (12.3) | 56 (49.1) | 84 (71.1) |
| | ||||||||
| | 97 (50.5) | 96 (50.0) | 33 (17.2) | 77 (40.1) | 12 (6.3) | 26 (13.5) | 95 (49.5) | 169 (88.0) |
| | 334 (36.9) | 468 (51.8) | 146 (16.2) | 339 (37.5) | 74 (8.2) | 132 (14.6) | 505 (55.9) | 757 (83.7) |
| | ||||||||
| | 137 (29.6) | 238 (51.4) | 98 (21.2) | 171 (36.9) | 27 (5.8) | 77 (16.6) | 250 (54.0) | 389 (84.0) |
| | 63 (45.7) | 82 (59.4) | 39 (28.3) | 60 (43.5) | 18 (13.0) | 15 (10.9) | 84 (60.9) | 127 (92.0) |
| | 30 (71.4) | 19 (45.2) | 11 (26.2) | 23 (54.8) | 4 (9.5) | 7 (16.7) | 25 (59.5) | 38 (90.5) |
| | 113 (47.7) | 136 (57.4) | 3 (1.3) | 92 (38.8) | 21 (8.9) | 34 (14.4) | 143 (60.3) | 208 (87.8) |
| | 88 (40.7) | 89 (41.2) | 28 (13.0) | 70 (32.4) | 16 (17.4) | 25 (11.6) | 98 (45.4) | 164 (75.9) |
| | ||||||||
| | 61 (22.0) | 100 (36.1) | 35 (12.6) | 65 (23.5) | 9 (3.3) | 25 (9.0) | 115 (41.5) | 186 (67.2) |
| | 300 (42.8) | 404 (57.6) | 137 (19.5) | 298 (42.5) | 62 (8.8) | 115 (16.4) | 413 (58.9) | 632 (90.2) |
| | 36 (53.7) | 35 (52.2) | 6 (9.0) | 30 (44.8) | 9 (13.4) | 8 (11.9) | 45 (67.2) | 63 (94.0) |
| | 34 (66.7) | 25 (49.0) | 1 (2.0) | 23 (45.1) | 6 (11.8) | 10 (19.6) | 27 (52.9) | 45 (88.2) |
| | ||||||||
| Total | 431 (39.3) | 564 (51.5) | 179 (16.3) | 416 (38.0) | 86 (7.8) | 158 (14.4) | 600 (54.8) | 926 (84.5) |
Figure 1Prevalence of CVD risk factors by gender (to be under the image): *Hypercholesterolemia.
Figure 2Ethnic differences in prevalence of CVD risk factors (to be under the image): *Hypercholesterolemia.
Logistic regression results of the cumulative1 CVD risk factor
| Adjusted | Crude | |
|---|---|---|
| | ||
| | Reference | Reference |
| | ||
| | 1.21 (0.13 - 10.71) | 2.34 (0.30 - 17.96) |
| | Reference | Reference |
| | 1.18 (0.44 - 3.18) | 1.53 (0.68 - 3.41) |
| | 1.90 (0.78 - 4.63) | 0.92 (0.47 - 1.81) |
| | 1.92 (0.72 - 5.11) | |
| | Reference | Reference |
| | 0.81 (0.47 - 1.39) | 0.70 (0.43 - 1.12) |
| | Reference | Reference |
| | 1.99 (0.89 - 4.45) | |
| | 2.13 (0.94 - 4.82) | |
| | ||
| | 2.12 (0.86 - 5.21) | |
| | Reference | Reference |
| | 1.93 (0.60 - 6.16) | |
| | 2.50 (0.89 - 7.05) | 1.22 (0.50 - 2.96) |
| | 3.09 (0.77 - 12.45) | 2.09 (0.56 - 7.87) |
| | Reference | Reference |
Note: 1. Existence of at least one CVD risk factor 2. Odds-Ratios 3. Confidence Interval (95%)
*. P < 0.05 **. P < 0.01 ***. P < 0.0001